Compared to the other research, the preventing efficacy of CMC
esophageal stents appears to be limited.
As a postoperative complication, the exposure of the stent graft into the esophagus is rare, and
esophageal stent insertion was effective.
fistula after Management bariatric surgery 1 2 months Not available 2 11 months Laparoscopic robotic-assisted esophagogastrectomy with Roux-en-Y reconstruction 3 13 years Partial gastrectomy, resection of the gastropleural fistula, hiatal hernia repair, & decortication 4 6 months Enteric stent insertion to cover the fistula opening 5 2 years Excision of the fistula & repair of the diaphragmatic defect 6 9 months Side-to-side esophagojejunostomy & jejunojejunostomy 7 2 months Over-the-scope clip at the gastric opening & endoscopic approach 8 11 years Endoscopic suturing &
esophageal stent placement 9 9 months Total parenteral nutrition, percutaneous drainage, & antibiotics with endoscopic stenting No.
Efficacy and safety of a new fully covered self-expandable non-foreshortening metal
esophageal stent. Gastrointest Endosc 2015; 80: 577-85.
Radiotherapy dose perturbation of metallic
esophageal stents. Int J Radiat Oncol Biol Phys 2002;54:1276-85.
In the past, the fully covered and partially covered WallFlex
Esophageal Stents have received CE Mark and US Food and Drug Administration (FDA) clearance for the palliative treatment of malignant esophageal strictures.
Most of the published literature regarding use of
esophageal stents in children has involved patients with refractory caustic strictures or esophageal stricture after esophageal atresia repair [1].
Esophageal stent placement or surgery is indicated when dilatation is not successful.
23 November 2009 - US-based medical devices company Boston Scientific Corporation (NYSE: BSX) announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex Fully Covered
Esophageal Stent for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients with resectable or non-resectable esophageal cancer.
Although this study is retrospective, a lot of countermeasures have been revealed for safe and effective
esophageal stent placement.